Effect of Tamarindus indica L. fruit pulp and seed extracts on experimental ulcerative colitis in rats

Mohsen Minaiyan , Sepehr Abolhasani, Setareh Sima, Afsaneh Yegdaneh

Abstract


Background and purpose: Tamarindus indica L. which has anti-inflammatory, radical scavenging, and ulcer healing effects can be useful for the alleviation of inflammatory bowel disease (IBD). Therefore, the effects of T. indica fruit pulp (TIPE) and seed extracts (TISE) were investigated on experimental colitis.

Experimental approach: TIPE and TISE (125, 250, and 500 mg/kg) were made by maceration (ethanol/water: 80/30) and administered to male Wistar rats with acetic acid-induced colitis. Prednisolone (4 mg/kg) and mesalazine (100 mg/kg) were used as reference drugs. The colon tissues were examined for macroscopic and pathologic parameters and myeloperoxidase (MPO) and malondialdehyde (MDA) values.

Findings/Results: The total phenols were 45.7 ± 1.1 and 453.0 ± 3.3 mg/g in terms of gallic acid for TIPE and TISE, respectively. Both of the extracts significantly improved most of the investigated parameters including body weight loss, the weight of colons, indices of ulcers, and total colitis. MPO activity and MDA in the treatment groups (except for TIPE at 125 mg/Kg) significantly decreased compared to the control.

Conclusion and implications: Both TIPE and TISE were effective in the treatment of colitis however it seems that the effective ingredients were more concentrated in seeds rather than pulp extract so the highest dose of seed extract had a competitive effect with reference drugs. More studies are needed to introduce T. indica as a suitable complementary medicine or food for patients with IBD.


Full Text:

PDF

References


Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2002;1:16(6):933-943.

DOI: 10.1053/bega.2002.0354.

Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-1517.

DOI: 10.1053/j.gastro.2004.01.063.

Guan Q. A Comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019;2019:1-17.

DOI: 10.1155/2019/7247238.

Summers RW. Novel and future medical management of inflammatory bowel disease. Surg Clin North Am. 2007;87(3):727-741.

DOI: 10.1016/j.suc.2007.03.004.

Klein A, Eliakim R. Non-steroidal anti-inflammatory drugs and inflammatory bowel disease. Pharmaceuticals. 2010;3(4):1084-1092.

DOI: 10.3390/ph3041084.

Rahimi R, Mozaffari S, Abdollahi M. On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies. Dig Dis Sci. 2009;54(3):471-480.

DOI: 10.1007/s10620-008-0368-x.

Rahimi R, Shams-Ardekani MR, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010;16(36):4504-5014.

DOI: 10.3748/wjg.v16.i36.4504.

Rao YS, Mathew MK, Potty SN. Tamarindus indica. Ind J Arecanut Spices Med Plants.1999;1:127-145.

DOI: 10.4103/0973-7847.79102.

Ibrahim NA, El-Gengaihi S, El-Hamidi A, Bashandy SAE. Chemical and biological evaluation of Tamarindus indica L. growing in Sudan. Acta Hortic. 1995;390:51-57.

DOI: 10.17660/ActaHortic.1995.390.6.

Kabir Khanzada, Shaikh W, Shahzadi S, Kazi T, Usmanghani K, Kabir A, et al. Chemical constituents of Tamarindus indica. Medicinal plant in Sindh. Pak J Bot. 2008;40(6):2553-2559.DOI: 4435/443543720011.

Wong Kc, Tan CP, Chow CH, Chee SG. Volatile constituents of the fruit of Tamarindus indica L. J Essent Oil Res. 1998;10:219-221.DOI: 10.1080/10412905.1998.9700886.

Nadkarni KM. Indian Materia Medica, 1st ed. Mumbai: Bombay Popular Prakashan; 1976. pp. 1191-1193.DOI: 10.4236/cm.2011.24024.

Kuru P. Tamarindus indica and its health related effects. Asian Pac J Trop Biomed. 2014;4(9):676-681.DOI: 10.12980/APJTB.4.2014APJTB-2014-0173.

Havinga RM, Hartl A, Putscher J, Prehsler S, Buchmann C, Vogl CR. Tamarindus indica patterns of use in traditional African medicine. J Ethnopharmacol. 2010;127(3):573-588.DOI: 10.1016/j.jep.2009.11.028.

Chhabra SC, Mahunnah RL, Mshiu EN. Plants used in traditional medicine in Eastern Tanzania, pteridophytes and angiosperms (Acanthaceae to Canellaceae). J Ethnopharmacol. 1987;21:253-277.DOI: 10.1016/0378-8741(87)90103-6.

Abubakar M, Yerima M, Zahriya AG, Ukwuani AN. Acute toxicity and antifungal studies of ethanolic leaves, stem and pulp extract of Tamarindus indica. Res J Pharm Biol Chem Sci. 2010;4:104-111.

Handa SS, Khanuja SPS, Longo G, Rakesh DD. Extraction technologies for medicinal and aromatic plants. 1st ed. Trieste: ISC-UNDO Publication; 2008. pp. 131-150.

Chandra S, Khan S, Avula B, Lata H, Yang MH, El-Sohly MA, et al. Assessment of total phenolic and flavonoid content, antioxidant properties, and yield of aeroponically and conventionally grown leafy vegetables and fruit crops: a comparative study. Evid Based Complement Alternat Med. 2014; 2014:1-10.DOI: 10.1155/2014/253875.

Kalra P, Sharma S, Suman, Kumar S. Antiulcer effect of the methanolic extract of Tamarindus indica seeds in different experimental models. J Pharm Bioallied Sci. 2011;3(2):236-241. DOI: 10.4103/0975-7406.80778.

Kumutarin T, Azadi S, Butterworth L, Keil D, Chitsomboon B, Suttajit M, et al. Extract of the seed coat of Tamarindus indica inhibits nitric oxide production by murine macrophages in-vitro and in-vivo. Food Chem Toxicol. 2004;42(4):649-658.DOI: 10.1016/j.fct.2003.12.001.

Minaiyan M, Ghannadi A, Mahzouni P, Nabi-Meibodi M. Anti-ulcerogenic effect of ginger (rhizome of Zingiber officinale Roscoe) hydroalcoholic extract on acetic acid-induced acute colitis in rats. Res Pharm Sci. 2008;3(2):79-86.

Niknami E, Sajjadi SE, Talebi A, Minaiyan M. Protective effect of Vitis vinifera (black grape) seed extract and oil on acetic acid-induced colitis in rats. Int J Prev Med. 2020;11:102,1-7.DOI: 10.4103/ijpvm.IJPVM_362_19.

Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114(3):385-391.DOI: 10.1046/j.1365-2249.1998.00728.x.

Motavallian-Naeini A, Minaiyan M, Rabbani M, Mahzuni P. Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat. EXCLI J. 2012;11:30-44.PMCID: PMC4919924.

Mahdavi NS, Talebi A, Minaiyan M. Ameliorative effect of galantamine on acetic acid induced colitis in rats. Res Pharm Sci. 2019;14(5):391-399.DOI: 10.4103/1735-5362.268199.

Khoramian L, Sajjadi SE, Minaiyan M. Anti-inflammatory effect of Adiantum capillus-veneris hydroalcoholic and aqueous extracts on acetic acid-induced colitis in rats. Avicenna J Phytomed. 2020;10(5):492-503.PMCID: PMC7508316.

Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, et al. Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg. 2011;54(5):333-338.DOI: 10.1503/cjs.013610.

Owusu G, Obiri DD, Ainooson GK, Osafo N, Antwi AO, Duduyemi BM, et al. Acetic acid-induced ulcerative colitis in Sprague Dawley rats is suppressed by hydroethanolic extract of Cordia vignei leaves through reduced serum levels of TNF-α and IL-6. Int J Chronic Dis. 2020;8785497:1-11.DOI: 10.1155/2020/8785497.

Keyvanara AH, Yegdaneh A, Talebi A, Minaiyan M. Evaluating anti-inflammatory effect of hydroalcoholic extracts of Citrus medica L. pulp and peel on rat model of acute colitis. Res J Pharmacognosy. 2023:10(2):29-38.DOI: 10.22127/RJP.2023.377466.2027.

Minaiyan M. Sajjadi SE, Naderi N, Taheri D. Anti-inflammatory effect of Kelussia odoratissima Mozaff. hydroalcoholic extract on acetic acid-induced acute colitis in rats. J Reports Pharm Sci. 2014;3(1):28-35.

Frankel EN, Meyer AS. The problems of using one‐dimensional methods to evaluate multifunctional food and biological antioxidants. J Sci Food Agr. 2000;80(13):1925-1941.DOI: 10.1002/1097-0010(200010)80:13<1925::AID-JSFA714>3.0.CO;2-4.

Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two model of colitis in rats. Gastroentrology. 1992;102(5):1524-1534.DOI: 10.1016/0016-5085(92)91710-l.

Naini MA, Zargari-Samadnejad A, Mehrvarz S, Tanideh R, Ghorbani M, Dehghanian A, et al. Anti-inflammatory, antioxidant, and healing-promoting effects of Aloe vera extract in the experimental colitis in rats. Evid Based Complement Alternat Med. 2021;2021.DOI: 10.1155/2021/9945244.

Karaoglan ES, Bayir Y, Albayrak A, Toktay E, Ozgen U, Kazaz C, et al. Isolation of major compounds and gastroprotective activity of Alchemilla caucasica on indomethacin induced gastric ulcers in rats. Eurasian J Med. 2020;52(3):249-253.DOI: 10.5152/eurasianjmed.2020.19243.

Sadraei H, Asghari G, Khanabadi M, Minaiyan M. Anti inflammatory effect of apigenin and hydroalcoholic extract of Dracocephalum kotschyi on acetic acid induced colitis in rats. Res Pharm Sci. 2017;12(4):322-329.DOI: 10.4103/1735-5362.212050.

Kim JW, Kim CY, Kim JH, Jeong JS, Lim JO, Ko JW, et al. Prophylactic catechin-rich green tea extract treatment ameliorates pathogenic enterotoxic Escherichia coli-induced colitis. Pathogens. 2021;10(12):1573,1-12.DOI: 10.3390/pathogens10121573.

Dangles O. Antioxidant activity of plant phenols: chemical mechanisms and biological significance. Curr Organ Chem. 2012;16(6):692-714.DOI: 10.2174/138527212799957995.38. Roja L, Jahan N, Wesley J. Antiulcerogenic activity of alcoholic extract of the leaves of Tamarindus indica L. on experimental ulcer models. Pharmacologyonline. 2008;3:85-92.

Periasamy S, Lin CH, Nagarajan B, Sankaranarayanan NV, Desai UR, Liu MY. Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis. J Funct Foods. 2018;47:1-10.DOI: 10.1016/j.jff.2018.05.035.

O’Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O’Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res. 2004;551(1-2):245-254.DOI: 10.1016/j.mrfmmm.2004.01.015.

Gupta M, Mishra V, Gulati M, Kapoor B, Kaur A, Gupta R, et al. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacol. 2022;30(2):397-434.DOI: 10.1007/s10787-022-00931-1.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.